WALTHAM, Mass., June 10, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (APLS) today announced that SYFOVRE ® (pegcetacoplan injection) preserved visual function at 36 months in patients with ...

SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting In a prespecified ...

Oscillator injection locking is an interesting subject; however, it seems to be a forgotten circuit concept that can be beneficial in some applications. Wow the engineering world with your unique ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Results presented at the American Academy of Orthopaedic Surgeons Annual Meeting showed hyaluronic ...

Please provide your email address to receive an email when new articles are posted on . Intra-articular injection of amniotic membrane/umbilical cord particulate may reduce pain and improve function ...